On August 13, 2025, President Trump signed an executive order aimed at strengthening America’s pharmaceutical supply chains. Officially titled “Ensuring American Pharmaceutical Supply Chain Resilience by Filling the Strategic...more
8/18/2025
/ Department of Health and Human Services (HHS) ,
Executive Orders ,
Government Agencies ,
Healthcare ,
Manufacturers ,
Most-Favored Nations ,
Patient Access ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prescription Drugs ,
Procurement Guidelines ,
Public Health ,
Supply Chain
Both President Trump’s and President Biden’s administrations have emphasized in executive orders and presidential memoranda the need for objective, science-based decision-making. However, Trump’s May 23, 2025, Executive Order...more
5/29/2025
/ Biden Administration ,
Diversity and Inclusion Standards (D&I) ,
Executive Orders ,
Government Agencies ,
OSTP ,
R&D ,
Regulatory Reform ,
Regulatory Requirements ,
Research and Development ,
Scientific Research ,
Transparency ,
Trump Administration